Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

Rigel Pharmaceuticals, Inc. RIGL

Full chart Compare
Set alert

Price alert · RIGL

All alert types
50.94 USD +2.08 (+4.25%)

Nov 4, 2026, 11:17 AM EST

49.23 Day range 50.96
24.95 52-week range 52.61
YTD
+18.92%
1 year
+79.47%

Financial health

Altman Z-Score

4.38 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

4 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 1
  • Return on Equity 5
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 4
  • P/B 4

Valuation

P/E 2.1×
FY 2016: -3.2×FY 2017: -6.3×FY 2018: -5.2×FY 2019: -5.3×FY 2020: -19.4×FY 2021: -24.1×FY 2022: -4.4×FY 2023: -10.1×FY 2024: 17.0×FY 2025: 2.1×
FY 2016 5y median -4.4× FY 2025
P/S 2.6×
FY 2016: 11.0×FY 2017: 109×FY 2018: 8.3×FY 2019: 6.0×FY 2020: 5.4×FY 2021: 3.0×FY 2022: 2.2×FY 2023: 2.2×FY 2024: 1.6×FY 2025: 2.6×
FY 2016 5y median 2.2× FY 2025
P/B 2.0×
FY 2016: 4.1×FY 2017: 4.9×FY 2018: 3.4×FY 2019: 6.7×FY 2020: 17.4×FY 2021: 14.9×FY 2022: -19.0×FY 2023: -8.8×FY 2024: 89.9×FY 2025: 2.0×
FY 2016 5y median 2.0× FY 2025
P/FCF 10.2×
FY 2016: -2.9×FY 2017: -6.3×FY 2018: -6.2×FY 2019: -8.3×FY 2020: -11.1×FY 2021: 86.0×FY 2022: -3.5×FY 2023: -12.2×FY 2024: 9.5×FY 2025: 10.2×
FY 2016 5y median 9.5× FY 2025
EV/EBITDA 6.0×
FY 2016: -3.3×FY 2017: -5.8×FY 2018: -4.2×FY 2019: -5.6×FY 2020: -21.6×FY 2021: -41.1×FY 2022: -5.1×FY 2023: -16.5×FY 2024: 10.5×FY 2025: 6.0×
FY 2016 5y median -5.1× FY 2025
EV/Sales 2.7×
FY 2016: 10.3×FY 2017: 101×FY 2018: 6.6×FY 2019: 6.3×FY 2020: 5.5×FY 2021: 3.1×FY 2022: 2.3×FY 2023: 2.4×FY 2024: 1.7×FY 2025: 2.7×
FY 2016 5y median 2.4× FY 2025
FCF Yield 9.8%
FY 2016: -34.1%FY 2017: -15.9%FY 2018: -16.2%FY 2019: -12.0%FY 2020: -9.0%FY 2021: 1.2%FY 2022: -28.7%FY 2023: -8.2%FY 2024: 10.5%FY 2025: 9.8%
FY 2016 5y median 1.2% FY 2025

Profitability

Gross Margin 93.3%
FY 2016: -211.3%FY 2017: -931.9%FY 2018: 99.4%FY 2019: 98.5%FY 2020: 99.2%FY 2021: 99.3%FY 2022: 98.5%FY 2023: 93.9%FY 2024: 89.6%FY 2025: 93.3%
FY 2016 5y median 93.9% FY 2025
Operating Margin 42.6%
FY 2016: -342.2%FY 2017: -1775.6%FY 2018: -163.3%FY 2019: -116.5%FY 2020: -26.7%FY 2021: -8.4%FY 2022: -46.2%FY 2023: -17.5%FY 2024: 13.5%FY 2025: 42.6%
FY 2016 5y median -8.4% FY 2025
Net Margin 124.7%
FY 2016: -339.6%FY 2017: -1739.3%FY 2018: -158.3%FY 2019: -112.2%FY 2020: -27.4%FY 2021: -12.0%FY 2022: -48.7%FY 2023: -21.5%FY 2024: 9.8%FY 2025: 124.7%
FY 2016 5y median -12.0% FY 2025
ROE 93.8%
FY 2016: -125.8%FY 2017: -77.5%FY 2018: -64.1%FY 2019: -123.7%FY 2020: -87.4%FY 2021: -59.0%FY 2022: 430.2%FY 2023: 87.6%FY 2024: 531.8%FY 2025: 93.8%
FY 2016 5y median 93.8% FY 2025
ROIC 28.2%
FY 2016: -125.6%FY 2017: -79.0%FY 2018: -65.3%FY 2019: -71.5%FY 2020: -37.1%FY 2021: -11.0%FY 2022: -79.1%FY 2023: -28.5%FY 2024: 21.3%FY 2025: 28.2%
FY 2016 5y median -11.0% FY 2025
ROA 71.5%
FY 2016: -88.6%FY 2017: -65.5%FY 2018: -50.7%FY 2019: -45.1%FY 2020: -26.9%FY 2021: -10.7%FY 2022: -43.6%FY 2023: -21.4%FY 2024: 10.7%FY 2025: 71.5%
FY 2016 5y median -10.7% FY 2025

Growth (YoY)

Revenue 64.1%
FY 2016: -29.5%FY 2017: -78.0%FY 2018: 892.6%FY 2019: 33.2%FY 2020: 83.2%FY 2021: 37.4%FY 2022: -19.4%FY 2023: -2.8%FY 2024: 53.4%FY 2025: 64.1%
FY 2016 FY 2025
Operating Income 418.6%
FY 2016: -34.8%FY 2017: -14.2%FY 2018: 8.7%FY 2019: 4.9%FY 2020: 58.1%FY 2021: 56.9%FY 2022: -344.5%FY 2023: 63.1%FY 2024: 218.1%FY 2025: 418.6%
FY 2016 FY 2025
EPS (diluted) 1867.7%
FY 2016: -25.9%FY 2017: 15.8%FY 2018: 28.7%FY 2019: 9.1%FY 2020: 55.0%FY 2021: 38.9%FY 2022: -209.1%FY 2023: 57.6%FY 2024: 168.7%FY 2025: 1867.7%
FY 2016 FY 2025
Free Cash Flow 143.5%
FY 2016: -220.1%FY 2017: -1.3%FY 2018: 22.9%FY 2019: 28.3%FY 2020: -24.4%FY 2021: 109.8%FY 2022: -1513.2%FY 2023: 72.0%FY 2024: 249.8%FY 2025: 143.5%
FY 2016 FY 2025

Financial Health

Current Ratio 2.4×
FY 2016: 3.4×FY 2017: 6.4×FY 2018: 4.9×FY 2019: 2.0×FY 2020: 2.2×FY 2021: 2.4×FY 2022: 1.8×FY 2023: 1.9×FY 2024: 2.1×FY 2025: 2.4×
FY 2016 5y median 2.1× FY 2025
Quick Ratio 2.3×
FY 2016: 3.4×FY 2017: 6.4×FY 2018: 4.9×FY 2019: 2.0×FY 2020: 2.1×FY 2021: 2.3×FY 2022: 1.6×FY 2023: 1.8×FY 2024: 2.0×FY 2025: 2.3×
FY 2016 5y median 2.0× FY 2025
Debt / Equity 0.1×
FY 2016: 0.1×FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.7×FY 2020: 1.1×FY 2021: 1.0×FY 2022: -3.1×FY 2023: -2.1×FY 2024: 18.2×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA 0.1×
FY 2016: 0.2×FY 2017: 0.5×FY 2018: 1.1×FY 2019: -0.2×FY 2020: -0.3×FY 2021: -1.0×FY 2022: -0.3×FY 2023: -1.6×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median -0.3× FY 2025
Interest Coverage 17.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 0.0×FY 2019: -206×FY 2020: -21.4×FY 2021: -2.6×FY 2022: -15.0×FY 2023: -3.0×FY 2024: 3.1×FY 2025: 17.1×
FY 2016 5y median -2.6× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31